Feedback / Questions
cintredekin besudotox (IL13PE38) - Precision NeuroMed
https://www.prnewswire.com/news-releases/precision-neuromed-granted-fda-orphan-drug-designation-by-us-fda-for-treatment-of-glioblastoma-multiforme-gbm-302575427.html
Oct 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next